CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. Between 75-95% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
Open platformOpen platform

Evotec Presents Plan Targeting EUR 75 Million in Annual Run-Rate Cost Savings by End-2027

By Public Technologies
  • Evotec signed a deal to sell its Toulouse biologics site to Sandoz for approximately US$ 350 million upfront, including technology licensing.
  • The agreement includes more than US$ 300 million in license, milestone and development revenue commitments for 2026-2028.
  • Royalties on 10 biosimilars offer additional revenue potential beyond 2028; six are in technical development.
  • The Horizon restructuring targets approximately 800 job cuts, reducing the global footprint from 14 sites to 10.
  • Expected annual run-rate savings reach approximately EUR 75 million by end-2027, against approximately EUR 100 million in total cash costs.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Evotec SE published the original content used to generate this news brief on November 06, 2026, and is solely responsible for the information contained therein.

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.